UCLA DA 253.01: Early Randomized Surgical Epilepsy Trial, Los Angeles Campus
Date:
March 23, 2004
From: Chancellor Albert Carnesale
To: Executive Vice Chancellor & Provost Daniel M. Neuman
Vice Chancellor, Research Roberto Peccei
Associate Vice Chancellor, Research and Executive Director, Office of Research Administration Andrew Neighbour
Assistant Vice Chancellor, Research Ann Pollack
Contract & Grant Manager Linda Lee
Contract & Grant Officer Tamara S. Combs
Grant Analyst Maya Conn
References:
  1. UC DA 2144 (Early Randomized Surgical Epilepsy Trial, Los Angeles Campus) to Chancellor Carnesale, dated February 27, 2004;
  2. Regents’ Standing Order 100.4(dd);
  3. UC DA 2036 (To Solicit and Accept or Execute Certain Extramural Grants and Contracts) to Chancellors, dated March 10, 1995;
  4. UCLA DA 250.07 (To Solicit and/or Execute Certain Extramural Grants and Contracts) to Executive Vice Chancellor Neuman, et al., dated June 24, 2003.
Supersedes: New

Effective as of the date above, I hereby delegate to you, in your areas of responsibility, the authority to solicit and execute any amendments, modifications, or renewals subsequent to the initial award for the project titled Early Randomized Surgical Epilepsy Trial provided the general intent and purpose of the program remain unchanged from those originally approved.

On March 10, 1995, the Chancellor was delegated authority to solicit and accept extramural grants and contracts for research not exceeding $5,000,000 in direct costs in any one project year (UC DA 2036). This authority was redelegated to you (UCLA DA 250.07, dated June 24, 2003), subject to the restrictions, exceptions and instructions outlined in UC DA 2036 and the additional specified dollar amount limitations.

Pursuant to the President’s authority, the University has executed a new cooperative agreement with the National Institutes of Health (NIH) and National Institute of Neurological Disorders and Stroke, in the initial amount of $7,142,493. The project entitled Early Randomized Surgical Epilepsy Trial commenced on September 1, 2002 and is expected to be funded through June 30, 2007. The total anticipated funding amount is $23,509,339.

This authority may not be further redelegated.


cc: Senior Vice President, Business & Finance
General Counsel & Vice President, Legal Affairs
Special Assistant, Coordination & Review
Administrative Policies Coordinator